Longitude goes live in Jersey
The first Longitude deployment opens in Jersey through participating GP practices and laboratories. Your own doctor orders the test, receives the result and goes through it with you.
News
The first Longitude deployment opens in Jersey through participating GP practices and laboratories. Your own doctor orders the test, receives the result and goes through it with you.

Lido Medical Practice in St Saviour is now offering Longitude to its patients. The test is ordered by the patient’s own GP, who receives the report and goes through it with them. From a single blood sample, Longitude estimates ten-year risk for heart attack, ischaemic stroke, type 2 diabetes, chronic kidney disease and fatty liver disease, often years before routine tests show a change.

Every Longitude sample taken on the island will be received, processed and dispatched to Nightingale Health’s United Kingdom laboratory by a single Jersey laboratory, under one documented procedure.

The Wellbeing Co., Lisa McCabe’s preventative health and occupational health business will offer Longitude alongside its existing clinic assessments and onsite corporate health check days.
Dr Charles Alessi, Chief Clinical Officer of Nightingale Health UK, presents Longitude at the Guernsey AI Sprint, introduced by Archipelago Health founder Dr Jeff MacLeod.
Archipelago Health has published its clinical reference material for doctors ordering Longitude: what the test measures, how the risk models were built, what the report contains and what the test does not do. The Clinical Science and Evidence Guide is available on request.
Longitude was presented publicly for the first time at the TEKEX Health Innovation event in Jersey, alongside the island's health technology sector.
Nightingale Health and Archipelago Health have entered into an agreement to bring the Nightingale Health Check to the Crown Dependencies, Bermuda and the Caribbean.
The two companies announced their partnership to bring preventive screening to small island health systems in the Crown Dependencies, Bermuda and the Caribbean.

One of the UK’s senior cardiometabolic physicians takes the clinical lead across our Crown Dependencies and Caribbean markets.
Archipelago Health is pleased to announce that Professor Andrew Krentz has joined as Chief Clinical Advisor.
Prof Krentz MB ChB MD PhD FRCP FRCPath FFPM FRSM FRSA is a cardiometabolic medicine specialist of long standing. He trained as an NHS consultant in general internal medicine, diabetes and endocrinology, and was Consultant Physician at Southampton University Hospitals for fourteen years. He is Visiting Professor at King’s College London and at the University of Reading, Editor-in-Chief of Cardiovascular Endocrinology and Metabolism, and founding co-editor of Diabetes, Obesity and Metabolism. He has written or edited six books and more than two hundred peer-reviewed papers, and is an accredited clinical specialist in hypertension.
As Chief Clinical Advisor he anchors the clinical case for Archipelago Health across the Crown Dependencies and the Caribbean, and has reviewed and signed off the Clinical Interpretation and Action Guide that supports clinicians reading an Archipelago Health report.

Bermuda’s former Chief Medical Officer brings population health and public-sector experience to the Archipelago Health advisory team.
Archipelago Health is pleased to announce that Dr Ayoola Oyinloye has joined as Senior Public Health Advisor.
Dr Oyinloye MB BS MSc MPH FFPH is a public health physician and a Fellow of the Faculty of Public Health. He was Chief Medical Officer of Bermuda from 2020 to 2023, where he led the territory’s response to the COVID-19 pandemic, chaired the Clinical Senate and served as Bermuda’s International Health Regulations focal point. He went on to be Director of Population Health Innovation and Strategy at the Bermuda Health Council, leading the Core Benefits Strategy and the redesign of the island’s chronic disease pathway. He has also been Chief Medical Officer of the British Indian Ocean Territory and Interim Director of Public Health at Swindon Borough Council, and is a co-signatory of the joint statement on antimicrobial resistance by the Chief Medical Officers of the UK Overseas Territories.
As Senior Public Health Advisor he advises Archipelago Health on the population health case for predictive screening and on engagement with public-sector and payer organisations across its island markets.